Application | Comment | Organism |
---|---|---|
medicine | antisense inhibition of PCSK9 is an attractive and novel therapeutic approach for treating hypercholesterolemia | Mus musculus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
ISIS 394814 | most potent antisense oligonucleotide. Administration to high fat-fed mice for 6 weeks reduces hepatic PCSK9 mRNA levels by 92%, total cholesterol and LDL by 53% and 38%, respectively. Inhibition of PCSK9 expression results in a 2fold increase in hepatic LDLR protein levels | Mus musculus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | - |
C57BL/6 mice | - |
Mus musculus C57BL/6 | - |
C57BL/6 mice | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
liver | - |
Mus musculus | - |
Synonyms | Comment | Organism |
---|---|---|
PCSK9 | - |
Mus musculus |
proprotein convertase subtilisin/kexin type 9 | - |
Mus musculus |